Know what to prove before the next move.
Follow-on funding and revenues depend on evidence that the technology can scale, customers will buy and the next move will remove the right constraint.
I independently test the technical claims, commercial assumptions and capital dependencies behind that decision.
You receive a clear written basis for what to prove, fund or change next – so investors, board, clients and team can act on the same evidence.
Start with a Transition Review: one decision, 2–3 weeks, with scope and fee agreed before the work begins.
For science-based ventures
1
Capital Strategy
I map suitable capital sources, sequencing and evidence requirements against commercial and technical milestones, so financing decisions support your venture’s transition.
For ventures that need to finance the next technical and commercial transition without defaulting to the wrong capital.
You receive:
-
a map of suitable capital sources and their sequencing
-
evidence requirements attached to each financing step
-
alignment of technical, commercial and financing milestones
-
identification of critical funding gaps and dependencies
-
a written capital and evidence strategy
Process: Document review, founder working session, capital pathway analysis and final readout. Timeline: 2–3 weeks.
Offers & Pricing in the brief below.
2
Transition Review
Clarify the next consequential move for your venture, scaleup or SME. Test what the evidence supports, identify the binding constraint and establish decision conditions before committing further time or capital.
-
Should we raise, partner, license or sell directly?
-
Is the current bottleneck technical, commercial, organisational or financial?
-
Which commitment should we make next, and which should we defer?
You receive:
-
an independent assessment of the decision
-
the binding constraint and relevant evidence gaps
-
a comparison of credible routes
-
explicit conditions for the next commitment
-
a 3–5 pages executive decision brief
Process: Evidence review, up to three stakeholder conversations and decision readout. Timeline: 2–3 weeks.
Offers & Pricing in the brief below.
3
Transition Architecture
I connect product development, go-to-market choices and capital into one coherent transition plan. You receive a roadmap around dependencies, evidence milestones and the commercial route your venture can credibly pursue.
For ventures that need to connect product development, market entry and capital into one executable transition plan.
You receive:
-
a 12–24 month integrated roadmap
-
technical, commercial and financing milestones
-
critical dependencies and evidence gates
-
route-to-market and partnership decision points
-
explicit conditions for investment, continuation or change
Process: Evidence review, targeted stakeholder interviews, architecture development and leadership workshop. Timeline: 5–7 weeks.
Offers & Pricing in the brief below.
Selected venture work
Semiconductors scaleup
Anonymised case · Denmark
THE PROBLEM
Technical capability needed a credible route to industrial adoption.
MY CONTRIBUTION
I connected buyer priorities, capability requirements and capital sequencing.
OUTCOME
An integrated commercial pathway with industrial evidence milestones and funding tied to decision gates.
Oncology venture
Anonymised case · Germany
THE PROBLEM
A scientific concept needed a staged product and development route.
MY CONTRIBUTION
I connected product definition, proof requirements, partners and financing.
OUTCOME
A venture model linking development milestones to evidence requirements, partner choices and capital needs.
Biomedical spinout
Anonymised case · Germany
THE PROBLEM
Research needed a first commercial offer and a credible spinout pathway.
MY CONTRIBUTION
I connected target buyers, pricing, costs, market entry and financing.
OUTCOME
A commercial plan with evidence gates and separate routes for pre-spinout evidence funding and post-spinout launch capital.